We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multitiered Molecular Control Mechanism Regulates T-cell Genetic Switch

By LabMedica International staff writers
Posted on 27 Jul 2016
Print article
Image: Cells labeled to identify proteins that regulate the expression of a genetic switch for T-cells. On the right, T-cells where the switch is activated glow in yellow. On the left, the rainbow pattern, a hierarchical cluster analysis, tells investigators which genes are controlled by the switch. The horizontal stripes are the genes. If they stripes turn red going from left to right, it means they are turning on; if they turn blue, the genes are turning off (Photo courtesy of the California Institute of Technology).
Image: Cells labeled to identify proteins that regulate the expression of a genetic switch for T-cells. On the right, T-cells where the switch is activated glow in yellow. On the left, the rainbow pattern, a hierarchical cluster analysis, tells investigators which genes are controlled by the switch. The horizontal stripes are the genes. If they stripes turn red going from left to right, it means they are turning on; if they turn blue, the genes are turning off (Photo courtesy of the California Institute of Technology).
Three distinct molecular processes act in a stage-specific manner to provide a multitiered system for regulating the T-cell developmental gene BCL11B (B-cell CLL/Lymphoma 11B).

During T-cell development, multipotent progenitors commit to the T-cell lineage by turning on the BCL11B gene, which encodes a transcription factor. To identify the factors responsible for controlling the commitment mechanism, investigators at the California Institute of Technology (Pasadena, USA) followed developing T-cells at the single-cell level using mice genetically engineered to express a fluorescent protein in addition to their own Bcl11b protein. This caused the mouse cells to glow under the fluorescent microscope when the BCL11B gene was activated.

Results published in the July 4, 2016, online edition of the journal Nature Immunology revealed that a group of four protein transcription factors cooperated in a series of multi-tiered steps to regulate the T-cell genetic switch.

Initially, the proteins HNF1 homeobox A (HNF1A; also known as TCF1) and GATA binding protein 3 (GATA3) performed an early locus "poising" function, which paved the way for the activation step. Next, Notch protein signaling activated BCL11B. The fourth protein, Runt-related transcription factor 1 (Runx1) controlled the amplitude of the signal.

"We identify the contributions of four regulators of BCL11B, which are all needed for its activation but carry out surprisingly different functions in enabling the gene to be turned on," said senior author Dr. Ellen Rothenberg, professor of biology at the California Institute of Technology. "It is interesting - the gene still needs the full quorum of transcription factors, but we now find that it also needs them to work in the right order. This makes the gene respond not only to the cell's current state, but also to the cell's recent developmental history."

Related Links:
California Institute of Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.